Verition Fund Management
CDMO

Verition Fund Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Verition Fund Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,103
Closed -$248K – 3817
2024
Q4 		$248K Sell
20,103
-34,119
-63% -$391K ﹤0.01% 2869
2024
Q3 		$617K Buy
54,222
+39,363
+265% +$395K ﹤0.01% 2192
2024
Q2 		$106K Buy
+14,859
New +$114K ﹤0.01% 2724
2023
Q4 		– Sell
-16,897
Closed -$160K – 2743
2023
Q3 		$160K Buy
16,897
+3,043
+22% +$36.6K ﹤0.01% 2035
2023
Q2 		$194K Buy
+13,854
New +$236K ﹤0.01% 1870
2021
Q4 		– Sell
-47,000
Closed -$1.01M – 2856
2021
Q3 		$1.01M Buy
47,000
+38,255
+437% +$923K 0.01% 918
2021
Q2 		$224K Buy
+8,745
New +$187K ﹤0.01% 1521

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Verition Fund Management's CDMO Position: Q1 2025 in Review

Verition Fund Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 20,103 shares — an estimated $248K sold.

Verition Fund Management first reported a position in CDMO in Q2 2021 and held it in 7 quarters. The position peaked at $1.01M in Q3 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Verition Fund Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 20,103 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $248K.
  • Verition Fund Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
  • Verition Fund Management's Avid Bioservices, Inc. Common Stock position peaked at $1.01M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.